LSBio
Monoclonal Mouse anti-Human TNFRSF10B / Killer / DR5 Antibody (clone DJR2-2 (2-6), Extracellular Domain)

Human peripheral blood lymphocytes stained with purified DJR2-2, followed by biotinylated anti-mouse IgG and Sav-PE

Monoclonal Mouse anti-Human TNFRSF10B / Killer / DR5 Antibody (clone DJR2-2 (2-6), Extracellular Domain)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Flow Cytometry, Immunohistochemistry (general)
Reactivity:Human
Format:Liquid
See all Human TNFRSF10B / Killer / DR5 antibodies →
$351.00each
Catalog Number: LS-C40990-100

For bulk orders or custom formulations:

Request a Quote

Overview

Description
DR5 antibody LS-C40990 is an unconjugated mouse monoclonal antibody to human DR5 (TNFRSF10B / Killer) (Extracellular Domain). Validated for Flow. Cited in 1 publication.
Application
FC, IHC
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
Cytotoxic TRAIL receptor-2 | CD262 antigen | DR5 | Death receptor 5 | KILLER | TRAIL-R2 | TRICK2B | TNFRSF10B | TRAILR2 | TRICK2A | TRICKB | TRICK2 | CD262 | Fas-like protein | TRAIL receptor 2 | ZTNFR9
UniProt Number
O14763|Q6FH58
NCBI GenBank
NM_147187
SwissProt
O14763

Target

Target
Human TNFRSF10B / Killer / DR5
Antigen Species
Human
Epitope
Extracellular domain of DR5-human IgG1 Fc fusion protein
Gene Name
TNFRSF10B

Antibody

Host Species
Mouse
Clonality
Monoclonal
Clone
DJR2-2 (2-6)
Isotype
IgG1

Immunogen

Immunogen
Recombinant human TNFRSF10B / DR5.
Immunogen Type
Recombinant Immunogen

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
Phosphate-buffered solution, pH 7.2, 0.09% sodium azide.
Concentration
0.5 mg/mL
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at 4°C. Avoid freezing.
Recommended Storage Buffer
Phosphate-buffered
Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma. Shi J, Tricot GJ, Garg TK, Malaviarachchi PA, Szmania SM, Kellum RE, Storrie B, Mulder A, Shaughnessy JD, Barlogie B, van Rhee F. Blood. 2008;111:1309-17. PubMed: 17947507 PMC: PMC2214736

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.